Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bioscience to Acquire Division of Genetronics Biomedical Corp

NEW YORK, Dec. 26 - Harvard Bioscience today announced an agreement for a $3.7 million purchase of the BTX division of Genetronics Biomedical Corporation.


The sale, subject to the approval of Genetronics' shareholders, is set to close by early February, according to Harvard Bioscience.


Terms of the sale also include a royalty on net sales of BTX products, which include electroporation and electrofusion devices.


In the fall, Harvard Bioscience acquired Genomic Solutions.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.